Cannabis Industry Insights

A Sobering Week for Cannabis Science; Why "It's Complicated" Is the Honest Headline

It was a humbling week for anyone who likes their cannabis science tidy. A major international study suggested that how a country legalizes matters more than whether it does.

Hype-Strain Genetics and 5mg Seltzers. How Summer 2026's Product Drops Reveal a Bifurcating Market

Walk into a dispensary this June and you can see two cannabis industries sharing the same shelf. On one side sit the trophy strains: small-batch, terpene-loud, genetics-obsessed flower that connoisseurs hunt by name.

The Clock Runs Down on Two Federal Deadlines That Will Define Cannabis for Years

Cannabis policy in the United States is being shaped this summer not by a single dramatic vote but by two ticking clocks, and this week pushed both closer to zero.

Earnings Season Splits the Industry in Two Record Revenue for the Disciplined, Fire Sales for the Over-leveraged

If you wanted a single snapshot of where the cannabis business stands in mid-2026, you could not have asked for a clearer one than the run of financial filings that landed this week.

A 240-Patient Study Makes the Case That Cannabis Can Spare Opioids

The most clinically meaningful cannabis study of the week did not involve a flashy molecule or a dramatic cure. It involved 240 patients living with a poorly understood, chronically painful condition

The 10-Milligram Rush — Cannabis Drinks Bulk Up Before the Federal Clock Runs Out

There is a quiet arms race underway in the cannabis beverage aisle, and this week it got louder.

As Rescheduling Inches Forward, Its Opponents Open a New Front in Court

Trulieve Rings the NYSE Bell — and the Industry Discovers Wall Street Was Never the Hard Part

For more than a decade, the dream of every American cannabis executive sounded roughly the same: someday, a plant-touching operator would trade on a major U.S. stock exchange like any other consumer business.

800 Milligrams of CBD and a Hard Truth About What Cannabis Can and Can't Treat

For the millions of people living with the relentless nerve pain that follows a spinal cord injury, the options have always been grim

The Sober-Curious Cannabis Drink Has Its Data — and a Big Week of Launches to Match

The most important cannabis product of the week wasn't a flashy new strain or a celebrity edible. It was a spreadsheet. On June 4, MoreBetter and the Network of Applied Pharmacognosy released findings from the largest real-world cannabis beverage study to date.